US EditionGenetic medicine can leave people with rare mutations behind. But there's new hope
- Patients with rare genetic mutations of cystic fibrosis have fewer treatment options than those with common mutations, as noted by researchers discussing mutation-agnostic gene therapies.
- Kramer-Golinkoff is diagnosed with cystic fibrosis due to a rare mutation, which current treatments cannot address, affecting 40,000 Americans diagnosed with the disease overall.
- Gene therapy trials at Columbia University aim to improve lung function and overall health, providing hope for patients with cystic fibrosis.
- Despite worsening health, Kramer-Golinkoff expresses optimism about future therapies, noting that having trials underway provides hope for those with cystic fibrosis.
Insights by Ground AI
Does this summary seem wrong?
46 Articles
46 Articles
All
Left
17
Center
17
Right
2
Los Angeles TimesReposted by 
Independent Español
Independent EspañolEmily Kramer-Golinkoff doesn't get enough oxygen with every breath.
·Los Angeles, United States
Read Full Article
Weighing cure for sick kids against troubling ethical questions — Harvard Gazette
Photos by Niles Singer/Harvard Staff Photographer Health Weighing cure for sick kids against troubling ethical questions Science Center talk outlines potential and risks of gene editing Clea Simon Harvard Correspondent April 28, 2025 4 min read If our differences are part of what make us human, do we have the right — or the responsibility — to change them? That question was at the crux of “…
·Harvard, United States
Read Full Article
Associated Press News+37 Reposted by 37 other sources
Genetic medicine can leave people with rare mutations behind. But there's new hope
People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid recent advancements in the growing field of genetic science.
·United States
Read Full ArticleCoverage Details
Total News Sources46
Leaning Left17Leaning Right2Center17Last UpdatedBias Distribution47% Left, 47% Center
Bias Distribution
- 47% of the sources lean Left, 47% of the sources are Center
47% Center
L 47%
C 47%
Factuality
To view factuality data please Upgrade to Premium
